Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, DOYLE THOMAS JAMES, holds the title of SVP, Finance & Accounting at Kura Oncology, Inc..
On 2026-11-16, the insider transacted 4,697 shares.The shares were transacted at a weighted average price of $7.44 per share, resulting in a total market-relevant value of $35K.
DOYLE THOMAS JAMES (SVP, Finance & Accounting) sold $35K of $KURA
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.